PATENT CLAIM ANALYSIS

Application Number: 15774891
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "183000"]

Abstract:
Described herein are unit-dose formulations of 1, 1′-[1,4-phenylenebis (methylene)]-bis- 1,4,8,1 l-tetraazacyclotet-radecane (“AMD3100”) and uses thereof as an anti-fugetactic agent.

Claim (Index 4):
The unit-dose formulation of  claim 1 ,\n wherein the unit-dose formulation is selected from the group consisting of liquid, solution, suspension, emulsion, elixir, syrup, electuary, mouthwash, drops, tablet, granule, powder, lozenge, pastille, capsule, cachet, pill, ampoule, bolus, suppository, pessary, tincture, gel, paste, ointment, cream, lotion, oil, foam, spray, mist, film, osmotic pump, bandage, dressing, depot, reservoir, injection solution or aerosol.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.06897
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11667410', '15840930', '15705631', '15672964', '14661656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7249991108444245
- 35 USC 102 Novelty (BERT): 0.4962819851809448
- Combined Prediction Score: 0.7021273982780766
- Mean Citation Score: 167.407058
- Max Citation Score: 177.42508
- Similarity Product: 108.28160706304551

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test